Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C WARREN

Showing results (101-110 of 1,117) with videos related to

Pageof 112
Sort By:
Biochimica Et Biophysica Acta|January 1, 1971
An estrophilic macromolecule in chicken liver cytosolF Arias, J C Warren
Neurology|April 7, 2010
The delayed-start study in Parkinson disease: can't satisfy everyoneC Warren Olanow, O Rascol
Movement Disorders : Official Journal of the Movement Disorder Society|May 15, 2021
Reply to: "A New Approach to the Development of Disease-Modifying Therapies for PD"Karl Kieburtz, C Warren Olanow
Journal of Health Care for the Poor and Underserved|May 8, 2007
Katrina perspectivesBailus Walker, Rueben C Warren
Movement Disorders : Official Journal of the Movement Disorder Society|February 8, 2013
Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?C Warren Olanow, Patrik Brundin
Movement Disorders : Official Journal of the Movement Disorder Society|October 14, 2014
Reply to: psychogenic movement disorders: what's in a name?Stanley Fahn, C Warren Olanow
JAMA Network Open|February 5, 2021
Trends in Heroin Treatment Admissions in the United States by Race, Sex, and AgeElodie C Warren, Andrew Kolodny
Movement Disorders : Official Journal of the Movement Disorder Society|April 12, 2005
Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategyC Warren Olanow, Joseph Jankovic
The American Journal of Nursing|October 30, 2001
Understanding rosacea. A guide to facilitating careK B Lindow, C Warren
Cell Motility and the Cytoskeleton|June 15, 2007
The contributions of microtubule stability and dynamic instability to adenovirus nuclear localization efficiencyJames C Warren, Lynne Cassimeris
Pageof 112

Showing results (101-110 of 1,117) with videos related to

Sort By:
Pageof 112
Biochimica Et Biophysica Acta|January 1, 1971
An estrophilic macromolecule in chicken liver cytosolF Arias, J C Warren
Neurology|April 7, 2010
The delayed-start study in Parkinson disease: can't satisfy everyoneC Warren Olanow, O Rascol
Movement Disorders : Official Journal of the Movement Disorder Society|May 15, 2021
Reply to: "A New Approach to the Development of Disease-Modifying Therapies for PD"Karl Kieburtz, C Warren Olanow
Journal of Health Care for the Poor and Underserved|May 8, 2007
Katrina perspectivesBailus Walker, Rueben C Warren
Movement Disorders : Official Journal of the Movement Disorder Society|February 8, 2013
Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?C Warren Olanow, Patrik Brundin
Movement Disorders : Official Journal of the Movement Disorder Society|October 14, 2014
Reply to: psychogenic movement disorders: what's in a name?Stanley Fahn, C Warren Olanow
JAMA Network Open|February 5, 2021
Trends in Heroin Treatment Admissions in the United States by Race, Sex, and AgeElodie C Warren, Andrew Kolodny
Movement Disorders : Official Journal of the Movement Disorder Society|April 12, 2005
Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategyC Warren Olanow, Joseph Jankovic
The American Journal of Nursing|October 30, 2001
Understanding rosacea. A guide to facilitating careK B Lindow, C Warren
Cell Motility and the Cytoskeleton|June 15, 2007
The contributions of microtubule stability and dynamic instability to adenovirus nuclear localization efficiencyJames C Warren, Lynne Cassimeris
Pageof 112